<unk>  is a renin inhibitor under development for the treatment of hypertension (high blood pressure). It was first developed by Hoffmann–La Roche in 1996.
Remikiren
Insulinoma surgery
Diabetic foot surgery
Fabry's disease surgery
Glasdegib
Acromegaly surgery
Hypoglycemia surgery
Liraglutide